(Q51310014)

English

Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.

scientific article published in November 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/22986437

Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. (English)

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/22986437

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

irritable bowel syndrome

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

William D Chey

1

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/22986437

Anthony J Lembo

2

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/22986437

Bernard J Lavins

3

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/22986437

Steven J Shiff

4

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/22986437

Caroline B Kurtz

5

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/22986437

Mark G Currie

6

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/22986437

James E MacDougall

7

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/22986437

Xinwei D Jia

8

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/22986437

James Z Shao

9

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/22986437

Donald A Fitch

10

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/22986437

Mollie J Baird

11

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/22986437

Harvey A Schneier

12

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/22986437

Jeffrey M Johnston

13

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/22986437

language of work or name

0 references

publication date

1 November 2012

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/22986437

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/22986437

107

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/22986437

11

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/22986437

1702-1712

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/22986437

Functional bowel disorders

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.254

21 January 2018

Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.254

21 January 2018

An evidence-based position statement on the management of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.254

21 January 2018

The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.254

21 January 2018

AGA technical review on irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.254

21 January 2018

Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.254

21 January 2018

Clinical practice. Irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.254

21 January 2018

Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.254

21 January 2018

Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.254

21 January 2018

Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.254

21 January 2018

Stool form scale as a useful guide to intestinal transit time

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.254

21 January 2018

Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.254

21 January 2018

Predictors of patient-assessed illness severity in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.254

21 January 2018

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.254

21 January 2018

Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scale

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.254

21 January 2018

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.254

21 January 2018

Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.254

21 January 2018

Functional bowel disorders and functional abdominal pain

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.254

21 January 2018

Responder analyses and the assessment of a clinically relevant treatment effect

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.254

21 January 2018

Identifiers

10.1038/AJG.2012.254

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/22986437

1 reference

Europe PubMed Central

3 April 2018

http://europepmc.org/abstract/MED/22986437

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51310014&oldid=1548035339"